Cochrane Evidence Synthesis and Methods ►

De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a network meta-analysis of randomised controlled trials

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

The objective of this review is to evaluate the available evidence in order to identify an optimal de-escalation strategy in terms of duration and type of therapy for patients with ACS treated with PCI. We will perform a NMA to appraise the safest and most efficacious combination of type and length of DAPT de-escalation.

This is a protocol.

Health topics:

Heart & circulation > Myocardial ischemia/coronary disease > Acute coronary syndrome

Published:

8 July 2021

Authors:

De Filippo O, Piroli F, Bruno F, Bocchino PP, Saglietto A, Franchin L, Angelini F, Gallone G, Alabed S, Gasparini M, Ahmad M, De Ferrari GM, D'Ascenzo F

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
De Filippo O, Piroli F, Bruno F, Bocchino PP, Saglietto A, Franchin L, Angelini F, Gallone G, Alabed S, Gasparini M, Ahmad M, De Ferrari GM, D'Ascenzo F. De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a network meta-analysis of randomised controlled trials (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 7. Art. No.: CD014813. DOI: 10.1002/14651858.CD014813.